Combined detection of aneuploid circulating tumor‐derived endothelial cells and circulating tumor cells may improve diagnosis of early stage non‐small‐cell lung cancer.

MLA

Lei, Yuanyuan, et al. “Combined Detection of Aneuploid Circulating Tumor‐derived Endothelial Cells and Circulating Tumor Cells May Improve Diagnosis of Early Stage Non‐small‐cell Lung Cancer.” Clinical & Translational Medicine, vol. 10, no. 3, July 2020, pp. 1–16. EBSCOhost, https://doi.org/10.1002/ctm2.128.

APA

Lei, Y., Sun, N., Zhang, G., Liu, C., Lu, Z., Huang, J., Zhang, C., Zang, R., Che, Y., Mao, S., Fang, L., Wang, X., Zheng, S., & He, J. (2020). Combined detection of aneuploid circulating tumor‐derived endothelial cells and circulating tumor cells may improve diagnosis of early stage non‐small‐cell lung cancer. Clinical & Translational Medicine, 10(3), 1–16. https://doi.org/10.1002/ctm2.128

Chicago

Lei, Yuanyuan, Nan Sun, Guochao Zhang, Chengming Liu, Zhiliang Lu, Jianbing Huang, Chaoqi Zhang, et al. 2020. “Combined Detection of Aneuploid Circulating Tumor‐derived Endothelial Cells and Circulating Tumor Cells May Improve Diagnosis of Early Stage Non‐small‐cell Lung Cancer.” Clinical & Translational Medicine 10 (3): 1–16. doi:10.1002/ctm2.128.